Eculizumab

Common brands: Soliris, Folic Acid, Multitam, Quiofic, Venexa

Top reporter: Alexion Pharmaceuticals Inc.

Complement Inhibitor [EPC]Corticosteroid [EPC]Vitamin C [EPC]Vitamin B12 [EPC]Vitamin D [EPC]
53,305
Total Reports
15,047
Serious Reports
5,459
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.24%)

Patient Demographics

Male
16,977
Female
25,215

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Eculizumab.

# Reaction Reports % of Total
1 FATIGUE 5,845
10.1%
2 OFF LABEL USE 4,658
8.0%
3 HAEMOGLOBIN DECREASED 3,904
6.7%
4 HEADACHE 3,463
6.0%
5 DEATH 2,621
4.5%
6 PYREXIA 2,398
4.1%
7 DYSPNOEA 2,162
3.7%
8 ASTHENIA 2,006
3.5%
9 NAUSEA 1,983
3.4%
10 DRUG INEFFECTIVE 1,906
3.3%
11 HAEMOLYSIS 1,854
3.2%
12 PLATELET COUNT DECREASED 1,820
3.1%
13 MALAISE 1,785
3.1%
14 BLOOD LACTATE DEHYDROGENASE INCREASED 1,581
2.7%
15 ABDOMINAL PAIN 1,537
2.6%
16 VOMITING 1,482
2.5%
17 PAIN 1,462
2.5%
18 BACK PAIN 1,408
2.4%
19 CONDITION AGGRAVATED 1,401
2.4%
20 HOSPITALISATION 1,361
2.3%
21 DIARRHOEA 1,332
2.3%
22 NASOPHARYNGITIS 1,326
2.3%
23 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1,213
2.1%
24 PNEUMONIA 1,154
2.0%
25 INCORRECT DOSE ADMINISTERED 1,127
1.9%
26 ANAEMIA 1,126
1.9%
27 DIZZINESS 1,072
1.8%
28 ARTHRALGIA 1,057
1.8%
29 BLOOD CREATININE INCREASED 1,046
1.8%
30 COUGH 1,037
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.